Route

Toll Brothers Announces New Luxury Home Community Coming Soon to the Florida Panhandle

Retrieved on: 
Tuesday, February 27, 2024

PANAMA CITY BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Breakwater , is coming soon to the Panhandle of Florida.

Key Points: 
  • PANAMA CITY BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Breakwater , is coming soon to the Panhandle of Florida.
  • Construction of the Toll Brothers Sales Center and model homes will begin this spring, and sales will start in late summer of 2024.
  • Breakwater is an exclusive, gated community featuring Toll Brothers’ award-winning coastal architecture situated on beautiful home sites, many with preserve or water views.
  • For more information on Breakwater and Toll Brothers communities throughout Florida, call (877) 958-1140 or visit TollBrothers.com/Florida .

Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial

Retrieved on: 
Wednesday, February 21, 2024

SAN MATEO, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the completion of enrollment in its 250-patient SUMMIT MAX clinical trial ( NCT05018650 ) evaluating the safety and effectiveness of its HiPoint™ 88 and HiPoint 70 Reperfusion Catheters as part of the MonopointⓇ Reperfusion System.

Key Points: 
  • SAN MATEO, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the completion of enrollment in its 250-patient SUMMIT MAX clinical trial ( NCT05018650 ) evaluating the safety and effectiveness of its HiPoint™ 88 and HiPoint 70 Reperfusion Catheters as part of the MonopointⓇ Reperfusion System.
  • SUMMIT MAX is the first FDA-approved aspiration thrombectomy trial which is randomized.
  • Randomized controlled trials provide the best clinical science and the SUMMIT MAX Trial compares the Route 92 Medical Monopoint System to the largest commercially available conventional aspiration system.
  • “Route 92 Medical is leading the way in neurovascular innovation technology, bringing clinicians complete solutions designed to improve endovascular thrombectomy procedure times and outcomes.

Global Anterior Uveitis (Iritis) Drug Pipeline Research Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 6, 2024

This report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anterior Uveitis pipeline landscape.

Key Points: 
  • This report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anterior Uveitis pipeline landscape.
  • A detailed picture of the Anterior Uveitis pipeline landscape is provided which includes the disease overview and Anterior Uveitis treatment guidelines.
  • The assessment part of the report embraces, in depth Anterior Uveitis commercial assessment and clinical assessment of the pipeline products under development.
  • Anterior Uveitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Global Psoriatic Arthritis Drug Landscape Research Report 2024: Comprehensive Insights About 20+ Companies and 25+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 6, 2024

This report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape.

Key Points: 
  • This report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape.
  • A detailed picture of the Psoriatic Arthritis pipeline landscape is provided which includes the disease overview and Psoriatic Arthritis treatment guidelines.
  • The assessment part of the report embraces, in depth Psoriatic Arthritis commercial assessment and clinical assessment of the pipeline products under development.
  • Psoriatic Arthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

GETTRX™ Named Official Credit Card Processor of NHRA in Multi-Year Partnership

Retrieved on: 
Thursday, February 8, 2024

NHRA officials announced that GETTRX™, powered by Global Electronic Technology and the fastest name in credit card processing, has been named the Official Credit Card Processor of NHRA as part of a multi-year agreement.

Key Points: 
  • NHRA officials announced that GETTRX™, powered by Global Electronic Technology and the fastest name in credit card processing, has been named the Official Credit Card Processor of NHRA as part of a multi-year agreement.
  • GETTRX has also built a strong reputation throughout the industry for its strong customer support and family-first attitude, which has also translated well to its growing partnership with NHRA.
  • “Fans trust NHRA events to deliver speed, and as the fastest name in credit card processing, our customers know GETTRX™ is all about speed, too.
  • As well as its status as Official Credit Card Processor of NHRA, GETTRX™ will be heavily involved with racing in the NHRA Mission Foods Drag Racing Series.

Alberto Bona and the Class40 IBSA Go to USA and Canada

Retrieved on: 
Friday, February 2, 2024

“This third season with the Class40 IBSA”, commented Bona, “opens with a legendary regatta.

Key Points: 
  • “This third season with the Class40 IBSA”, commented Bona, “opens with a legendary regatta.
  • The Class40 IBSA is automatically qualified, thanks to her participation in the 2022 Route du Rhum.
  • In 2023, Bona and the Class40 IBSA participated in six regattas, including the Rolex Fastnet Race and the Transat Jacques Vabre.
  • IBSA: IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano.

Thor Equities Group Reaches Construction Milestones Across Industrial Portfolio

Retrieved on: 
Thursday, January 25, 2024

Nearby in Passaic, Thor Equities is planning to kickoff construction at 153 Linden Street to improve both the existing site and buildings to transform the facility for modern-day industry.

Key Points: 
  • Nearby in Passaic, Thor Equities is planning to kickoff construction at 153 Linden Street to improve both the existing site and buildings to transform the facility for modern-day industry.
  • Thor Equities has been active in the high-performing Northeast industrial market for years and owns additional properties in Newark, Brooklyn, and Deer Park, Long Island.
  • Outside of the Northeast, Thor owns industrial assets in California, Georgia, Texas, Pennsylvania, and Illinois in the US.
  • “Thor Equities is proud to reach these construction milestones and we look forward to keeping up the strong development momentum across our entire portfolio,” said COO of Thor Equities Group, Melissa Gliatta.

FreshByte Software Releases Cloud-Based Solution for Wholesale Food Distribution

Retrieved on: 
Friday, January 26, 2024

HOUSTON, Jan. 26, 2024 /PRNewswire-PRWeb/ -- FreshByte Software announced today the release of FreshByte Online, a new cloud-based solution that will offer more functionality and features to help small to large enterprises streamline their wholesale food distribution processes.

Key Points: 
  • FreshByte Software announced today the release of FreshByte Online, a new cloud-based solution that will offer more functionality and features to help small to large enterprises streamline their wholesale food distribution processes.
  • HOUSTON, Jan. 26, 2024 /PRNewswire-PRWeb/ -- FreshByte Software announced today the release of FreshByte Online , a new cloud-based solution that will offer more functionality and features to help small to large enterprises streamline their wholesale food distribution processes.
  • "The release of this web-based application is the culmination of a lot of hard work from our entire team at FreshByte," said FreshByte CEO Trevor Morris.
  • Morris called today's software release a celebration on many levels as FreshByte continues to evolve along with emerging technology and customer needs.

Route 92 Medical Announces the 100th Patent for its Neurovascular Intervention Portfolio

Retrieved on: 
Monday, January 8, 2024

SAN MATEO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio.

Key Points: 
  • SAN MATEO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio.
  • We will also focus on growing our product portfolio and improving operational effectiveness to enable us to scale our business for commercial success.”
    Route 92 Medical’s first step in revolutionizing neurovascular intervention is focused on acute ischemic stroke.
  • Route 92 Medical has a global intellectual property position with strong protection for its inventions in key markets including the U.S., Europe, and China.
  • The company's patent portfolio is growing rapidly with eight patents issued in 2023, including patents with claims across the company’s Monopoint® portfolio, including its Tenzing® and HiPoint™ catheter devices.

Ethernet and IP Testing Software for LANs and WANs

Retrieved on: 
Thursday, November 16, 2023

This cost-effective real-time testing solution is designed for Local Area Networks (LANs) and Wide Area Networks (WANs).

Key Points: 
  • This cost-effective real-time testing solution is designed for Local Area Networks (LANs) and Wide Area Networks (WANs).
  • GL’s PacketCheck™ is a versatile, user-friendly PC-based Ethernet and IP software program designed for testing and verifying LANs and WANs.
  • “PacketCheck™ offers extensive Ethernet testing, covering all protocol layers, from basic Ethernet frames to stacked VLAN, MPLS, and IP packets with UDP data.
  • It uses the PC’s Network Interface Card (NIC) to send and receive Ethernet and IP packets on LANs and WANs,” said Vijay Kulkarni, CEO of GL Communications.